INTELLIGENCE IN ACTION

HIMSS19 Highlights: Five Takeaways from Healthcare Leaders on Prescription Price Transparency

March 15, 2019

Judging by recent news headlines and my social media feed, this year’s HIMSS gathering seemed to be the most exciting and energized yet—not only because of the many emerging technologies under discussion and on display, but also the overall sense that the industry is making real progress, and positively impacting patient care in some very real ways. And the Surescripts Network Alliance™ led discussions throughout the show that demonstrated this impact through the lens of a very hot topic: prescription price transparency.

In true collaborative form, Dr. Steve Miller, Chief Clinical Officer of Cigna, and Dr. Troyen Brennan, Executive Vice President and Chief Medical Officer of CVS Health, joined Surescripts CEO Tom Skelton on stage for Views from the Top: Price Transparency in Prescription Drug Costs.




Check out the highlights video, which details:

  1. Why patients give up on their meds: Many patients choose to abandon treatment, due to delays that result from additional administrative work associated with their prescription, or out-of-pocket cost.


  2. The “horrible experience” that makes patients question their healthcare choices: Dr. Miller self-admittedly shares that doctors are too busy “making love to their keyboard” to truly connect with patients and provide high-quality care.


  3. How a little retail therapy might help: A more consumer-centric approach that mimics other positive online shopping experiences can empower patients and help inform their healthcare buying decisions.


  4. The real-time tool trio that’s changing the game: Three key technologies that, when combined, create a dramatically improved consumer experience—without unnecessary headaches at the pharmacy.


  5. And the mountain of money we can save: In addition to improved quality and safety, find out just how much money we can save every year by deploying these technologies at the point of care.

As our experts shared, the tools that will revolutionize patient-provider interaction are available today. Watch the full-length video to learn more. 

Related Articles

March 04, 2020

Prescription Price Transparency: Good for Patients, Good for Health Plans

Receiving a diagnosis at a routine doctor’s appointment can be incredibly scary, even for something as treatable as type 2 diabetes. But the right price transparency tools—or lack thereof—can make (or break) that experience for a patient.  Read more...
February 25, 2020

Price Transparency: It’s in the Best Interest of Patients and Providers

“In all my years in health IT this is one of the most exciting and most rapidly adopted clinical decision support tools I’ve ever been associated with,” said Andrew Mellin, MD and vice president of Medical Informatics at Surescripts, referring to Surescripts’ prescription price transparency tool Read more...
February 18, 2020

Patients Are Ready to Talk Dollars with Their Doctors

With more skin in the game than ever before, patients are becoming savvy, engaged and discerning consumers. They know that the name-brand drug with the $300 monthly price tag may not be the only option. They want a healthcare provider who has the information needed to compare and guide them to alternatives that achieve the same or similar outcome. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX